Results for mineralization translation from English to Maltese

mineralization catalyst
katalist tal-mineralizzazzjoni

mineralization of the sample
mineralizzazzjoni tal-kampjun

a 300 ml egg-shaped mineralization flask with a long neck.
flixkun ta' minerallizzazzjoni forma ta' bajda ta' 300 ml b'għonq twil.

the amounts of the reagents used for mineralization (6.1.):
l-ammonti tar-reaġenti użati għall-mineralizzazzjoni (6.1.):

if the reading is not zero mineralization was incomplete and analysis must be repeated.
jekk il-qari mhux żero, l-mineralizzazzjoni ma kinetx kompluta u l-analiżi trid tiġi rrepetuta.

after mineralization, the mercury liberated is measured by flameless atomic absorption.
wara l-mineralizzazzjoni, l-merkurju meħlus huwa mkejjel b'assorbiment atomiku ta' mingħajr fjamma.

strensiq has shown benefits for patients’ mineralization of the skeleton and growth.
strensiq wera benefiċċji fil-mineralizzazzjoni tal-iskeletru u tkabbir tal-pazjenti.

after appropriate preparation of the sample (wet or dry mineralization and purification).
wara l-preparazzjoni xierqa tal-kampjun (mineralizazzjoni u purifikazzjoni niexfa jew imxarrba).

pharmacotherapeutic group: drugs affecting bone structure and mineralization, bisphosphonates, atc code: m05ba08
kategorija farmakoterapewtika: mediċini għall-kura ta’ mard tal-għadam, bisfosfonati, kodiċi atc: m05ba08

in growing rats, there was no evidence of impaired mineralization even at doses greater than 5,000 times the dose required for osteoporosis treatment.
f’firien li kienu qed jikbru, ma kien hemm l-ebda evidenza ta’ tnaqqis fil- mineralizzazjoni anki f’dożi ta’ aktar minn 5,000 darba akbar mid-doża meħtieġa għall-kura ta’ l- osteoporożi.

an expected decrease in bone turnover, normal quality of bone and absence of defects in mineralization were also seen after two years of treatment with bondenza 3 mg injection.
dehru ukoll tnaqqis mistenni fil-bidla ta’ l-għadam, kwalità normali ta’ l-għadam u nuqqas ta’ difetti fil- mineralizzazjoni wara sentejn ta’ kura b’injezzjoni ta’ bondenza 3 mg.

pharmacotherapeutic group: drugs for the treatment of bone diseases – other drugs affecting bone structure and mineralization, atc code: m05bx04
kategorija farmakoterapewtika: mediċini għall-kura ta’ mard ta’ l-għadam – mediċini oħra li għandhom effett fuq l-istruttura ta’ l-għadam u l-mineralizzazzjoni, kodiċi atc: m05bx04

although narrowing of the neuroforamen and stenosis was observed, no mineralization of the dura, no spinal cord stenosis, and no neurological deficits subsequent to the application of inductos were observed.
għalkemm kien osservat it-tidjiq tan-newroforamen u stenosi, ma kienet osservata l-ebda mineralizzazzjoni tad-dura, l-ebda stenosi tas-sinsla, u l-ebda tnaqqis newroloġiku wara l-għoti ta’ inductos.

weekly repeated dosing of two to twenty times the clinical dose from one week of age through maturation resulted in extensive mineralization of tissues, which produced localized effects, such as ulcerative dermatitis, compromised circulation and hepatic dysfunction.
dożaġġ ripetut kull ġimgħa ta’ minn tnejn sa għoxrin darba tad-doża klinika sa mill-età ta’ ġimgħa sal-maturazzjoni, irriżulta f’mineralizzazzjonii estensiva tat-tessut, li pproduċiet effetti lokalizzati, bħal dermatite ulċerattiva, ċirkolazzjoni kompromessa u disfunzjoni tal-fwied.

during laboratory tests, form non-extractable residues in amounts exceeding 70 % of the initial dose after 100 days with a mineralization rate of less than 5 % in 100 days,
matul it-testijiet fil-laboratorju, jiffurmaw residwi li ma jistgħux jiġu estratti f'ammonti li jaqbżu s-70 % tad-doża inizzjali wara 100 jum b'rata ta' mineralizzazzjoni ta' inqas minn 5 % f'100 jum,

member states shall, where the evaluation carried out under part b, point 2.5.1.1, does not exclude the possibility of the plant protection product reaching the soil under the proposed conditions of use, evaluate the impact on microbial activity such as the impact on nitrogen and carbon mineralization processes in the soil after use of the plant protection product according to the proposed conditions of use.
meta l-evalwazzjoni mwettqa skond il-parti b, punt 2.5.1.1, ma teskludix il-possibbiltà li l-prodott għall-protezzjoni tal-pjanti jilħaq il-ħamrija skond il-kondizzjonijiet proposti għall-użu, l-istati membri għandhom jevalwaw l-impatt fuq l-attività tal-mikrobi bħalma huwa l-impatt fuq il-proċessi tal-mineralizzazzjoni tan-nitroġenu u tal-karbonju fil-ħamrija wara l-użu tal-prodott għall-protezzjoni tal-pjanti skond il-kondizzjonijiet proposti għall-użu.